[Comment] Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes
Sumber 柳叶刀 LancetBaru saja
Ringkasan konten
This item is a English-language original; headline and summary shown as published.
Cardiovascular outcomes trials with GLP-1 receptor agonists, which to date have largely comprised peptide analogues of the incretin hormone GLP-1, have evolved…
Situs ini hanya menyediakan indeks judul dan ringkasan, konten lengkap dan hak cipta sepenuhnya milik penerbit asli, silakan klik tautan asli untuk membaca.
Buka artikel asli- Saluran terkait
- Kesehatan
- Wilayah terkait
- Inggris
- Bahasa asli
- English
- Nomor entri
- health-1d503d72
Comments 0 comments
No comments yet. Be the first.